Loading the company…
Loading the company…
㈜토리든
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Daejeon, founded in 2015. Industry: Cosmetics (K-Beauty). Revenue for 2025 was ₩274.3bn. It has 219 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Qualified”.
Loading…
Latest filing 2023-09-15 · latest registration 2023-11-15 · newest first
본 발명은 5D 복합콜라겐을 함유하는 피부 주름 개선 및 보습용 화장료 조성물에 관한 것이다. 더욱 상세하게는 호두 씨앗, 흰목이버섯, 아까시나무 꽃, 히비스커스 꽃 및 동백나무 꽃으로부터 얻어진 콜라겐들 중 2종 이상을 포함하는 복합 콜라겐을 유효성분으로 포함하는 피부 주름 개선 및 보습용 화장료 조성물에 관한 것이다. 본 발명에 따른 복합 콜라겐을 유효성분으로 포함하는 화장료 조성물은 세린-팔미토일 전이효소 발현의 증가를 통한 세라마이드 생합성 촉진 효과, Claudin-1 단백질 발현 증가 효과, Laminin-5 단백질 발현 증가 효과를 통해 피부 장벽을 개선시켜 피부 겉 탄력 및 보습 효과를 가지고, 히알루론산 생성량 증가, Collagen Type 1, Elastin 단백질 발현의 증가 효과를 통해 피부 속 탄력 및 보습 효과를 가지며 이를 통해 피부 주름 개선 및 보습 효능을 갖는다.
본 발명의 락토바실러스를 이용한 병풀, 접시꽃, 푸른연꽃, 쓴풀 발효물의 제조방법은 병풀, 접시꽃, 푸른 연꽃, 쓴풀을 혼합 및 추출하여 혼합추출물을 수득하고, 상기 혼합추출물에 락토바실러스 쿠르바투스 J2K-01(기탁번호: KCTC 13494BP)을 접종하여 발효시킨 후, 침전물과 유산균체를 제거하여 발효물을 제조하는 것을 특징으로 한다. 본 발명에 의해, 피부 진정, 염증 개선, 상처 치유 및 재생에 효과가 있는 화장료 조성물이 제공된다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 2 of 2 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 186.0 | 274.3 |
| Cost of sales | 71.9 | 100.3 |
| Gross profit (loss) | 114.0 | 174.0 |
| Selling, general and administrative expenses | 62.0 | 113.6 |
| Operating income (loss) | 52.0 | 60.4 |
| Non-operating income | 2.7 | 2.6 |
| Other gains | 0.0 | 0.2 |
| Finance income | 0.6 | 1.3 |
| Other | 2.2 | 1.0 |
| Non-operating expenses | 0.5 | 1.2 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.0 | — |
| Other | 0.5 | 1.1 |
| Profit (loss) before tax | 54.2 | 61.8 |
| Income tax expense | 10.5 | 12.4 |
| Net income (loss) | 43.7 | 49.5 |
Revenue ₩274.3bn, up 47.5% YoY.
Operating margin 22.0% (prior 28.0%).
Net income ₩49.5bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-05